Camden National Corporation’s Eli Lilly LLY Stock Holding History

Camden National Corporation’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$853K	Buy	+4,569	New	+$894K	0.17%	74

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Camden National Corporation's LLY Position: Q1 2021 in Review

Camden National Corporation opened a new position in Eli Lilly (LLY) in Q1 2021: 4,569 shares worth $853K. The stake represents 0.17% of the portfolio and ranks #74 among its holdings.

1,948 funds tracked by Wall St. Rank hold LLY as of Q1 2021.

Camden National Corporation held 4,569 shares of Eli Lilly worth $853K as of Q1 2021.
Eli Lilly was a new Camden National Corporation position in Q1 2021.
Eli Lilly made up 0.17% of Camden National Corporation's portfolio in Q1 2021, its #74 holding.
1,948 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.

Based on Camden National Corporation's 13F filing for Q1 2021, filed 12 May 2021.